EyeWorld China December 2017

ĘNJˈlj Ѯ चů %: . ܭ ਐ˦˸ę י ć ė & ͱŘĪ뻟ĕƞʇ̾Ā ˦˸Ă ݎ Ąů 24- ͱ .#5+- ܭ ਐ뺯चů %:. ܭ ਐӣʇ̾˦˸ Ą ܭ ਐġ೚Դ੾뻟ƦƳ˸Ą ܭ ਐ ̡˪뺯 ߇ िɕֶؘŀćņŭ ߇ ि Ƀʭ ච Š ାʾƋ׷ֶŀƓĜ ' 5%45 Ĝ ڱ ĘζгąŇ ܪ ٣ 2 K :. ܭ ਐӣʇ̾˦˸Ā ތࠕ ls ư뻟#XGFTQ Āζг͎ė뺯 ćſŚƥʌ뻟Ĉȱǘ . #5 + - :VTC #XGFTQ Ā ތࠕ 뻟%:. ԓ ʸ .#5+- ͱ 24-뺯qĈĂȏը֪ ׅФ뻟ĕƞ ܭ ਐƑĻ٩ԏ뻟ĻĩĜ ܱӣşŀԴ੾จ˚Āɧٛ뻟r&T 4CLRCN ĸ뺯 # X G F T Q ũ֐ Ā ࡥ ռ Ɉ ԥ뻟2K:. ܭ ਐӣʇ̾˦˸Ā ތࠕ lsưȝŖɋīė뻟ƔŶĄ 2K:. ܭ ਐƳ˸뻟&T 4CLRCN ĸ뺯 CXL 和感染性角膜炎 Ĉȱ %:. ܭ ਐժཕȡ뻟ŬཕȡŠ ᚯ ث Мֹ Ɨઍ뻟ԪćĂȏ ڱڌ 뻟ę Ġ̾ĄćŚʌ뺯ϝǡħٜlsưͨ ࡋ 뺯qঽ ڝ 뻟ɋʿժཕƗઍٔ ٯ Ѣ ˆŖČ뻟ƦŬཕƗઍģٔ ٯ Ĉв뺯 Ţǘ ᚯ ث Мֹ ƗઍĀǟůăࢵ ǭ뻟r&T 4CPFNGOCP ĸ뺯 qāΞħlsưĈȏ٣ᘋƪ Ļ뻟r&T *GTUJ ĸ뺯qĈĂȏζ ƆׅФĈв뻟ԨĂȏׅФŠ̙ Ֆ ܭ ਐŊĈ ࡋו 뺯rŴşƍŢǘ Ⱥಧćů़Ā׀ٚʼnƬ뻟ģʼnĈ Џʬ뺯 获得报销 ĢȮſŚ࣪Ѥ %:. ŘĎ뻟Ăċɝ ʚĄζܽ뺯ȢƧ &T *GTUJ ϱŜ Ā뻟%:. ĕ׮Ƌ׷Ȍī࣪ѤǨΫ ɍĀŪǕπ˩Ƭ뻟Ʀ̀đ ܭ ਐĀ ਮ͠׻ȠŢևŇ뺯qŠ ۽ ˀ࣪Ѥ ăǜ뻟 ۽ ˀĻŘ ܭ ਐŪԮĘ΃ਮ ͠뻟ćſŚĀࠦᩕԴ੾ŠԴ੾จ ˚ਮ̾͠π˩Ň뻟rŴĸ뺯Ŵģ͎ ėȌī (&# ࣪Ѥ̀đǥУ ŭ Ĵǎ뺯 qǟħɕֶؘŀ뻟āĶʼnᒳ ྩ뻟ȂħĕŢਮ͠ʼnĈ͍Ҳ뻟āĶ ЏʬĩʼnČŞϙů뻟rŴĸ뺯 ĕƞᅍؗਇ̹ą #X G F T Q 4GKODWT UGOGPV %WUVQOGT *WD #4%* ֻϝĀǰੌ뺯ĕċ ֻϝৗՎζܽਁɑŠ౓ι뻟ъՎ Ŧȏăĩж ޚ ͗ůĀਮ͠뻟& T 4CLRCN ĸ뺯 '9#2 ৠ٧ͩ뻭NJġֶŀŠ #XGFTQ Ĉǁ ࢖ϙॼȱͷ뺯 ԓͷƶК Hersh: phersh@vision-institute.com Rajpal: rrajpal@seeclearly.com Randleman: JamesBradley.Randleman@ med.usc.edu ŭ ʃ EWAP ঃᓜᄌ 33 Views from Asia-Pacific Colin CHAN, MD Vision Eye Institute L3 270 Victoria Avenue, Chatswood, NSW, Australia Tel. no. +61-2-94249999 colchan@gmail.com Ⰿ ⻶㵀よ⥖⫉☧ )'$ ㈾㽜☨㦫㥒⼺㑉㨹➼ᮣ㵀≲▙⺉㫳ᱨ╹ ㅰ㋲ⳟ㈾㽜⒋⥂㖳㱫Ⰿ⻶ᱨ㚱⌔⢄☨ⰵ⥗㽼㝛㗁⧝☨ᮣ 㵀≲▙⺉㫳ゃ㱸ㅰ⼰㦎㺨ᱨ⧧ 'U 5DL]PDQ 㮥㬥ᱨ㣄➂㦆 )'$ ⯿ Ⰿ⻶☨ㅰ⼰㦎㺨㵀 㚢⭆㮾㔋㱸㨗⼺㑉⸵⫋ᮣ㸡㑥㚳㚱㙭☨ᱨ✛ 㟣⪔㸃Ⰿ⻶㱸➧⒋⶙ⶏ☨≠㐩㗷⳯ ᱨ㣄⒋⥂⢖ 㚢㮾㥲✛㟣㾖 Ⰿ⻶ᮣ㸆㨗⪔✛➧⒋㱪⡰ᱨ⧶㔕㎩ⷆ⏯㩖㮔㾖㐩⿳ᮣ㮥⊑ᱨ㣄➂㦆 ㅰ㎡⪔㸃☨⫄㽧➔㱎⢚タ㦄ᱨ㯜╱㣄㖳㱫⍙ギ䭞㝛⬺㚐☨㖫⭺⪹⢚ ⒌ᱨ㻒⏧⮋⼋ᮣ㱸㮥㨗⪔㸃ᱨ㑥⥗⵺㖶㺰⼒㖫㜡ㅰ㎡ᱨ㣄⏥☧⏥㵀 ㅰ⨍㴿╴㾖Ⰿ⻶ᮣ 'U 5DL]PDQ 㺚ⓞ⤴⮒㗁ᱨㅍ㨗 㚢㮾㥲⪔✛⢚㩖㮔㾖Ⰿ⻶ᱨ㯜 㢜㚳わ☨⭈⏋ⱌ㷝⢚ⶼᮣ㣄㠞㐩㟠㯌ᮣⱌ㷝⥙ⶼ⼺㸆㨗⪔㸃㵀⢚㨏 ☨㖫⨌ⳟ㩖㮔㾖Ⱋㄪ㮰㺔ᮣ㣄⪹㸆ぼ⧧⭨⒌ⰶ㗇ᱨ⶙㮾⹻ⰶᱨㅍ㨗 ⭨⒌⛶㲂㚳わ≜✛㵀㸆ぼ㨏ⳟ㮔㾖㗐㗯⪹➧⒋ⱈ㷩ᮣ㑥⥗⧶ⶼⳟ⶙ ㅢ㮔㾖Ⱋㄪ㮰㺔ᱨ㣄➂㦆⭨⒌⪹ⶼ㚑ⴈ⛊㫍㵗Ⰿ⻶ᮣ 㣄⛶㲂ㅰ㎡⪔㸃☨➝➈⿞㱸⍜㲂 'U %HUGDKOᮣ㚳㙭㑥⥗ゃ㱸⭝⿆ ☡㴘㽖Ⱋㄪ☨☼㨼㟰ⱌ㷝ᱨ㚳⏥㴞㯌㺓Ⱗⳟ⢖ㅰ㎡⪔㸃㾖Ⰿ⻶ᮣ㵀 ⥙㐣 ㅰ⹽ᱨ㣄㺣㔕㱸 ⢔ㅰ㎡⪔㸃⭈⏋ゃ㱸ⓞ㦆ⱌ㷝ᱨ㝎⍜㗁 ㅍ㨗㱸タ㦄⥙ゼ㩂⭈⏋⒋⒋㮔㑞㬇☨⪔㸃ᮣ㸆㨗⪔㸃ᱨ㣄⤠⺆㚳わ ⏥㮔㑞㬇Ⲹᱨ⢖㚳わ╌➝➪▙㥨⊩㢺⛊⭗⺋㑥 =DGLWHQ ⡙⿷㚙㟞 㝜➲☲㬇㮤ᱨ1RYDUWLVᱨ%DVHOᱨ6ZLW]HUODQG ⫊ 3DWDQRO 㫺㚙≰ ⿯㚳⛊☲㬇㮤ᱨ$OFRQᱨ)RUW :RUWKᱨ7H[DV ᱨ⒋⥂㖳㱫 Ḷ ⢔ 㴨⊝㻜㚳わ⡢㸡㥠⤻ᮣ㑥⥗⥙ゼ⢚㫻㺺ᱨ㣄⪹⯿㸆㨗⪔✛㽊㸓⢖ ⥙ゼⶖ㮧㔶ᱨⶌ⿑㠅ゼ オ㯉㺰⼒ᮣ㐹⨍㣄⪹➧⒋イ㎐⤷␖㸆㨗⪔ ✛ᱨょ ⢔㴨㾖㮥╴☼㨼㟰⮂␓ᱨ㣄㟠㯌㸆㨗⪔✛⶙㮾ⱌ㷝☼⧶ ⶼᱨ㔱㺣ょ ⢔㴨㻛ⳇ⡢⍐ Ḷ 'ᮣ ㅅ㍰㵀≲▙⺉㫳ᱨ㮥㨗Ⱋㄪ㽈ⶖ㮧㔶㾖Ⰿ⻶⧧☼㨼㟰㎐㦧ᮣ㣄☇ 㨲ᱨ⭊㖳㗁㾖⥙Ⰿ⻶☨Ⱋㄪᱨ㑥⥗Ⱋㄪ⌧㎐㦧⼗ᱨ⶙ㅢ⪹㱸⭎ㅰ⨍ 㴘㽖Ⱋㄪⱌ㷝☨⟇㦅ᮣ㣄㋜▣ⶄ☡☼㨼㟰㎐㦧⧧Ⰿ⻶☨ ㅰ㗷⳯ᱨ 㣄⛶╱⪑㗁⏥㜡➥㨲ᮣ 㣄㽂㯌☡⼗ 3URI 5DQGOHPDQ ⛶㲂⭩㚑Ⰿ⻶☨㋂⿥ᱨ㣄㋜▣ⶄ☡ ⢚✂☨㗷⳯ᮣ㣄㮥㺓㵀㾖㐣㔋㊦Ⰿ⻶ᱨ⏳㱫 $YHGUR 㥥㟧ᱨ㦆㵀㮻 ⲿ⒔⥙ ㅰ⼗ᱨ㣄⛶ⰵ⥗㮥㺓⧶〄㯌ᮣㅅ㍰⪑ゃ㱸ⓞ㦆㩖㮔㴿╴㺰 ⼒☨⏋⺋ᮣ㣄㐵㖯㮜➂㦆ᱨ⭩㚑➝≦⧧㴓 89; ⍖㽜 ➶㺵㷹㔠㦐 ⌴ᱨ⫄㽧㨼⒱⒴⛪⢚㎡ᮣ㸆⶙ㅢ㯌㢨㽥▕☡☨Ⰿ⻶⒴⛪⢚㎡ᱨ☏㗁 㸆⶙ㅢ㮜㾃⤗⼗ᱨ㯜㢜㣄わ⏌⏥㺌☤⛶㲂㝎⛊☨⪔㸃ᱨ㢜⼗㾈㺛㴘 㽖Ⱋㄪ☨ⱌ㷝㖯⭠㔋㩖㮔✂▙⼋☨Ⰿ⻶ᮣ㖼㖯㔋ᱨ㣄㥓㠯⯿⹂㣄わ ㅢ⤗⢗⳯㔶㣡⫒㨣㝎㩂⧧⪔㸃☨ㅰ⼰ⲽ㥨♛㸟Ⰿ⻶⼋ᱨ╹✚⍈オ✐ 㠖☨⏥⍄㮔☨Ⰿ⻶ᮣ 参考文献 1. Panos GD, Kozeis N, Balidis M, Moschos MM, Hafezi F. Collagen Cross-Linking for Paediatric Keratoconus. Open Ophthalmol J. 2017 Jul 31;11:211–216. doi: 10.2174/1874364101711010211. eCollection 2017. 2. Viswanathan D, Kumar NL, Males JJ. Outcome of corneal collagen crosslinking for progressive keratoconus in paediatric patients. Biomed Res Int. 2014;2014:140461. doi: 10.1155/2014/140461. Epub 2014 Jun 11. 3. Vinciguerra P, Albé E, Frueh BE, Trazza S, Epstein D. Two-year corneal cross- linking results in patients younger than 18 years with documented progressive keratoconus. Am J Ophthalmol. 2012 Sep;154(3):520–6. doi: 10.1016/j. ajo.2012.03.020. Epub 2012 May 24. ⍌⭃㽂ᱶ'U &KDQ 㔵タゃ㱸㦐⤴ⲿ⭙⺉㯐⤴㥥ᮣ ιԓ ܭ ਐ Ď۷ ǨĈ , $TCFNG[ 4CPFNGOCP /&